COX-2 plays a critical role in the pathophysiology of numerous diseases, including inflammatory conditions and malignancies, and is strongly associated with increased tumor aggressiveness, metastasis, and poor clinical outcomes [8, 32, 33]. This evidence concerns the gene PTGS2 and neoplasm.